Complete OTP Clinic Software + Billing Solution for Methadone Clinics
One integrated platform for dosing, compliance, documentation, billing, accountability, and revenue cycle. MASE OTP EMR + EliteMed billing services + Growth Bridge eligibility — built specifically for methadone clinics, not adapted from generic behavioral health software.
See the complete OTP solution
15-minute demo • Live MethaSpense + SciLog walkthrough • OTP billing review included
What is an OTP complete solution?
An OTP complete solution is a single connected stack that runs an opioid treatment program end-to-end: clinical EMR, methadone dispensing and pump synchronization, identity and accountability controls, 42 CFR Part 2 privacy architecture, DEA Form 222 and PMP/MAPS workflows, OTP weekly bundle billing, denial management, and revenue reporting. The MASE + EliteMed bundle pairs the MASE OTP EMR — with native MethaSpense and SciLog pump sync, facial biometric verification, geofencing, digital callback policy automation, and serialized bottle tracking — with EliteMed Financials’ specialized OTP billing services at 2.85% of collections. Together they handle G2067, G2068, G2078, G2079, G2086–G2088, H0020, H0033, prior authorizations, denial appeals, and weekly bundle workflows. Growth Bridge eligibility can make the EMR effectively free for qualifying OTP/MAT providers.
What an OTP operating system actually has to do
“OTP clinic software,” “methadone clinic management system,” “OTP EMR and billing,” and “complete OTP solution” all describe the same underlying job: running an opioid treatment program safely, compliantly, and profitably. Here’s the unpacked version.
The clinical layer
An opioid treatment program is regulated under SAMHSA 42 CFR Part 8 and operates with controlled-substance dispensing under DEA oversight. Software at this layer must handle methadone and buprenorphine dosing decisions, track medication-assisted treatment (MAT, also called MOUD — medications for opioid use disorder), document induction and maintenance phases, and support take-home decisions under SAMHSA’s revised post-COVID flexibility (up to 28 unsupervised take-home doses for stable patients). Concretely, that means: prescriber order entry, pump synchronization with dispensing hardware (MethaSpense, SciLog, Ivek-manufactured pumps), serialized bottle tracking for take-home supply, callback policy automation, diversion-risk scoring, group and individual counseling notes, periodic assessments, and treatment plan reviews — all linked to the right patient under the right consent.
The compliance layer
OTP records carry 42 CFR Part 2 protections that go beyond HIPAA. Re-disclosure is restricted, consent must be granular, and SUD records can’t be casually merged into a general patient record. On the controlled-substance side, the platform must support digital DEA Form 222 ordering, two-person verification logs, inventory reconciliation, and state Prescription Monitoring Program (PMP) or MAPS submissions where required. Joint Commission behavioral health care standards add documentation expectations around treatment plans, medication management, and patient rights. The software should generate compliance evidence as a byproduct of normal clinical work — not as a separate audit project.
The billing & revenue layer
OTP billing has its own coding structure. Medicare uses weekly bundle G-codes (G2067 methadone, G2068 buprenorphine, G2073 naltrexone) with take-home add-ons (G2078, G2079) and intake/assessment codes (G2076, G2077, G2080). Medicaid varies by state — NY OASAS uses bundle rate codes 7969/7973 for methadone, 7971/7975 for buprenorphine, with separate take-home rate codes (7970/7974, 7972/7976). Commercial in-network billing relies on H-codes (H0020, H0033, H0047), and office-based opioid treatment (OBOT) uses the G2086–G2088 sequence. Place of service 58 and ICD-10 F11.20 are mandatory on most claims. Generic billing teams often miss revenue when OTP-specific bundle rules, add-on codes, and payer-specific requirements are not configured and audited correctly.
The accountability layer
This is the layer most generic platforms underbuild. Take-home methadone is a regulated controlled substance leaving a clinic, going home with a patient. The software has to verify the right patient is taking the right dose at the right time — which is why MASE combines facial biometric verification, geofencing, and serialized bottle tracking, then layers diversion-risk scoring on top. The same accountability stack supports callback policy execution: when a patient is randomly called back for a bottle count, the workflow is digital, time-stamped, and audit-ready. This is also where the bundle’s clinical-to-claim integrity matters: if the EMR says a dose was dispensed, the billing system bills it; if the EMR says it was missed, the billing system doesn’t. Less re-keying. Fewer silent revenue leaks.
Clinical, financial, and access — engineered together
Most OTPs glue together a generic behavioral-health EMR, a separate billing company, and a third dispensing tool. The bundle connects three operating layers into one coordinated workflow.
MASE OTP EMR
The clinical engine. Purpose-built for methadone clinic workflows — not a generic behavioral-health configuration.
- MethaSpense + SciLog pump synchronization
- Facial biometric verification + geofencing
- Digital callback policy automation
- Serialized bottle tracking + diversion scoring
- DEA Form 222 + PMP/MAPS workflows
- AI clinical guidance during patient care
- 42 CFR Part 2 native architecture
EliteMed OTP Billing
Specialized OTP revenue cycle management — clean-claim discipline, payer-specific rules, weekly bundle expertise.
- OTP weekly bundle billing (G2067/G2068)
- Take-home add-ons (G2078/G2079)
- Office-based MAT (G2086–G2088)
- Commercial codes (H0020, H0033, H0047)
- Prior authorization handling
- Denial appeals: CO-22, CO-50, CO-96, CO-197
- 2.85% of collections — transparent
Growth Bridge
A financial access program that lowers — or removes — the upfront EMR subscription cost for qualifying OTP/MAT providers.
- Eligible providers may qualify for $0/mo EMR subscription
- Removes the $799+/mo software cost barrier
- Designed for startup + scaling clinics
- Not a loan — eligibility-based
- Pairs with EliteMed billing services
- Fast eligibility check during demo
- Helps qualified OTPs move faster toward launch readiness
MASE + EliteMed vs. standalone EMRs vs. standalone billers
Most OTP buyers compare a clinical EMR against a billing company against a generic behavioral-health platform. Here is the same comparison, capability-by-capability, in one place.
| Capability | MASE + EliteMed Complete Solution | Standalone OTP EMR | Standalone Billing Company | Generic Behavioral Health Platform |
|---|---|---|---|---|
| OTP-specific dosing workflow | OTP-focused workflow | Usually yes | Out of scope | Often adapted, not native |
| MethaSpense + SciLog pump sync | Native workflow | Varies by vendor | Out of scope | Rarely supported |
| Biometric verification + geofencing | Combined, native | Often separate add-ons | Out of scope | Not typical |
| Take-home dosing accountability | Bottle tracking + risk scoring | Logging only, varies | Out of scope | Limited |
| Digital callback policy automation | Built-in | Often manual | Out of scope | Rare |
| DEA Form 222 + inventory workflows | Digital + audit-ready | Varies | Out of scope | Not typical |
| 42 CFR Part 2 architecture | Native consent + segmentation | Varies | Limited to claim data | Often configurable, not native |
| OTP weekly bundle billing (G2067/G2068) | Specialized, daily | Not in scope | Depends on OTP focus | General coding only |
| Prior authorization handling | End-to-end | Out of scope | Yes, but separate from EMR | Module-dependent |
| Denial management (CO-22, CO-50, CO-96, CO-197) | Coded + appealed | Out of scope | Yes, payer-mix dependent | Often basic |
| Clinical-to-claim data flow | Connected workflow, less re-keying | Export to biller | Receives files from EMR | Module integration required |
| Revenue reporting | Unified clinic + RCM dashboard | Clinical KPIs only | Financial only | Generic reporting |
| Implementation timeline | Typical 14–30 days | 30–90 days common | 2–4 weeks billing-only | 60–120 days common |
| Cost barrier / upfront cost | Growth Bridge can lower or eliminate EMR cost | Often $799+/month | Percent-of-collections | Often per-user, scales fast |
| Best fit | OTPs that want one accountable partner | OTPs with mature in-house billing | Clinics keeping their current EMR | Multi-program behavioral health |
Capabilities for non-MASE/EliteMed solutions vary by vendor, configuration, and contract scope; “varies” and “often” reflect the broad market based on publicly available product documentation and our implementation experience as of 2026.
From the dispensing window to a paid claim — without re-keying
One patient visit, one connected workflow. The clinical record creates the billable event, and the billable event is reconciled back into the patient record. Nothing falls between two systems.
Patient arrives
Self check-in, queue management, facial biometric verification, geofencing confirms eligibility for take-home or in-clinic dose.
MASE handles dosing + clinical
MethaSpense/SciLog pump pulls the prescribed dose. Counseling, periodic assessments (G2077), psych eval, and take-home decisions documented in one chart.
Clinical data → EliteMed billing
Encounters route to the correct weekly bundle code (G2067/G2068) with take-home add-ons (G2078/G2079), F11.20 dx, POS 58. Less data entry duplication.
Claims → Revenue → Reports
Clean claims submitted, denials worked (CO-22, CO-50, CO-96, CO-197), patient responsibility crossed over for duals, weekly KPIs returned to leadership.
For deeper EMR-only detail, see the MASE OTP EMR page. For deeper billing-only detail, see EliteMed OTP Billing Services.
The codes the bundle handles, in one place
OTP billing is its own discipline. Generic medical billers miss revenue on the take-home add-ons, mix up Medicare versus Medicaid bundle behavior, and struggle with dual-eligible crossovers. EliteMed’s coding desk lives in this code set every day.
| Code | What it covers | Payer scope | Bundle fit |
|---|---|---|---|
| G2067 | Medication-assisted treatment, methadone weekly bundle (dispensing/administration, counseling, individual/group therapy, toxicology testing if performed) | Medicare OTP | Native |
| G2068 | Medication-assisted treatment, buprenorphine (oral) weekly bundle | Medicare OTP | Native |
| G2073 | Medication-assisted treatment, naltrexone (oral & monthly injection) | Medicare OTP | Native |
| G2074 | MAT weekly bundle — not including the drug (for members completing treatment) | Medicare OTP | Native |
| G2076 | Intake activities including initial medical examination | Medicare OTP add-on | Native |
| G2077 | Periodic assessment with treatment plan update | Medicare OTP add-on | Native |
| G2078 | Take-home supply of methadone (up to 7 additional days; max 4 units in 28 days) | Medicare + Medicaid | Native — preferred over H0020 |
| G2079 | Take-home supply of buprenorphine oral (up to 7 additional days) | Medicare + Medicaid | Native — preferred over H0033 |
| G2080 | Each additional 30 minutes of counseling beyond standard 120 minutes (with modifier 95 for audio-only) | Medicare OTP add-on | Native |
| G2086 / G2087 / G2088 | Office-based opioid use disorder treatment (70 min initial / 60 min subsequent / +30 min) | Medicare OBOT | Native (OBOT pathway) |
| G0137 | Intensive outpatient services; minimum 9 services in 7 contiguous days (requires authorization) | Medicare OTP | Native |
| G0532 | Take-home supply of nasal nalmefene HCl (effective 1/1/2025) | Medicare OTP add-on | Native |
| G0534 / G0535 / G0536 | Coordinated care & referral / patient navigation / peer recovery support (each additional 30 min) | Medicare OTP add-ons | Native |
| G2215 / G1028 | Take-home nasal naloxone (4mg / 8mg) | Medicare OTP | Native |
| H0020 | Alcohol/drug services; methadone administration (provision by licensed program) | Commercial in-network | Native — fallback to G2078 where preferred |
| H0033 | Oral medication administration, direct observation buprenorphine | Commercial in-network | Native — fallback to G2079 where preferred |
| H0047 | Alcohol/other drug services, naltrexone (oral & monthly injection) | Commercial in-network | Native |
| 90791 | Diagnostic evaluation (MAT intake / assessment) | Commercial + Medicaid | Native |
| 90832 / 90834 / 90837 | Psychotherapy 30 / 45 / 60 minutes | Commercial + Medicaid | Native |
| 99205 / 99212–99215 | E/M new and established patient (induction, maintenance) | Commercial + Medicaid + Medicare | Native |
| F11.20 | ICD-10: Opioid dependence, uncomplicated (primary diagnosis) | All payers | Auto-applied |
| POS 58 | Place of service: non-residential opioid treatment facility | All payers | Auto-applied |
Codes shown reflect publicly published CMS, SAMHSA, and commercial payer (e.g., Optum) guidance available as of 2026. Always verify current code requirements with each payer prior to submission. Modifier usage, frequency limits, prior authorization, and bundle/add-on combinations vary by payer; EliteMed’s coding desk applies the correct combination at claim time.
Denials we work daily, by reason code
The most common OTP denials are recoverable when caught early and worked correctly. The bundle reduces the volume at the front (clean claims) and works what survives at the back (appeals).
| Reason code | What it means | How EliteMed works it |
|---|---|---|
| CO-22 | Care covered by another payer | Verify primary/secondary order, run COB, resubmit to correct payer with updated coordination data |
| CO-45 | Charge exceeds fee schedule / contracted amount | Adjust to allowed amount, take contractual write-off, audit fee schedule for re-negotiation flags |
| CO-50 | Service not deemed medically necessary | Strengthen EMR documentation (treatment plan, periodic assessments, F11.20 dx specificity), file appeal with clinical justification |
| CO-96 | Non-covered charge(s) | Re-verify benefits, confirm in-network status (commercial OTP is in-network only for HCPCS H-codes), correct or appeal |
| CO-197 | Pre-certification / authorization absent | Submit retroactive authorization where allowed, document medical necessity, prevent recurrence with prior-auth workflow tightening |
| CO-234 | Procedure not paid separately | Re-bundle correctly under weekly bundle codes (G2067/G2068) with valid add-ons (G2078/G2079/G2080) |
OTP bundle ROI calculator
Estimate how the MASE + EliteMed bundle compares to your current EMR + billing setup. Adjust the inputs — the math updates instantly.
Number of unique patients you serve in a typical month.
Subscription you pay today for your EMR / clinic management software.
If you bill in-house, enter your effective cost as % of collections.
Total revenue collected per month across payers.
Estimated impact
This calculator is an estimate only. Actual savings depend on payer mix, denial rate, collection volume, implementation scope, current contract terms, and Growth Bridge eligibility. EliteMed billing is 2.85% of net collections under standard terms.
Get my custom ROI in a 15-min demo →An EMR cost barrier that often disappears for qualifying OTP/MAT providers
Growth Bridge is a financial-access program for opioid treatment programs and MAT providers that meet eligibility criteria. For qualifying providers, the monthly MASE EMR subscription can be reduced — or eliminated — when paired with EliteMed billing services. It is not a loan. There is no equity stake. There is no balance to repay later.
It exists because OTP buyers consistently tell us the same thing: “We want the right software, but the $799–$2,000+ per month subscription kills the budget before we ever launch.” Growth Bridge removes that line item for clinics that qualify.
Who tends to qualify
- Startup methadone clinics in pre-launch or first-year operations
- Existing OTPs paying $799+/mo on AZZLY, Kipu, or generic platforms
- OTP/MAT providers who use EliteMed for billing and RCM
- Multi-site clinics consolidating onto one OTP-specific stack
- Clinics committed to a meaningful monthly patient volume
- Providers serving Medicaid, Medicare, and dual-eligible populations
Eligibility, terms, and qualifying volumes are confirmed during the demo and depend on factors including patient volume, billing service engagement, state-specific reporting needs, and clinic operational readiness. Nothing on this page constitutes a binding offer; final terms are documented in your service agreement.
OTP-grade controls baked into every workflow
Methadone clinics carry a heavier compliance load than most healthcare settings. The bundle is engineered so that compliance evidence is created automatically as staff do their normal work — not bolted on at audit time.
HIPAA-aware workflows
Encryption, role-based access, audit trails, minimum-necessary defaults, and breach-response readiness across the platform.
42 CFR Part 2 architecture
Native consent capture, granular re-disclosure controls, and segmented data flows that keep SUD records protected end-to-end.
DEA controlled-substance workflow
Digital DEA Form 222, serialized bottle tracking, two-person verification logs, and PMP/MAPS submission workflows.
SAMHSA OTP alignment
Workflows mapped to SAMHSA OTP regulations covering admission, induction, take-home phases, periodic reviews, and diversion control.
Joint Commission readiness
Documentation evidence, treatment plan reviews, periodic assessment reminders, and audit packets aligned to BHC standards.
Audit-ready logs
Every login, every dose, every take-home decision, every consent change is timestamped, signed, and retrievable on demand.
Role-based access controls
Front desk, nursing, prescriber, billing, and administrator roles each see only the data they need to do their job.
State reporting workflows
State-specific PMP and registry submissions, OASAS-style bundle rate codes (e.g., 7969/7973), and required periodic reports.
The platform is designed to support compliance with federal and state OTP requirements; final compliance responsibility rests with the licensed provider. We support operational adherence — we are not your legal counsel.
From kickoff to go-live in 14–30 days
Standard OTP configurations move fast. Multi-site or heavy-migration projects extend the timeline, but the work plan stays the same.
Discovery + design
- Workflow mapping (intake → dosing → take-home → discharge)
- Payer mix review + fee schedule audit
- State reporting requirements
- Initial system configuration
Build + train
- Data migration from current EMR
- Pump integration (MethaSpense, SciLog, Ivek)
- Staff role-based training
- Billing fee schedule + payer rules loaded
Validate
- Parallel run on selected patients
- Claim workflow testing (G-codes + add-ons)
- Compliance evidence verification
- Take-home and callback policy dry-runs
Go-live + optimize
- Full clinic cutover
- Daily monitoring during stabilization
- Weekly RCM + clinical KPI reporting
- 30/60/90-day optimization checkpoints
Three operating profiles where the bundle wins
New methadone clinic preparing to launch
Pain: Capital tied up in licensing, real estate, and DEA work; can’t absorb a $1,500/mo EMR + a billing company’s setup fee.
Growth Bridge can take the EMR subscription to $0 for qualifying providers, while EliteMed billing handles enrollment, payer credentialing support, and weekly bundle workflows from day one. The clinic launches on an OTP-specific stack instead of a generic platform that has to be re-platformed in year two.
See startup playbook →Established OTP leaving AZZLY, Kipu, Methasoft, or paper
Pain: Paying $799–$2,000+/mo, dosing not synced to billing, denials piling up on G2078/G2079, take-home accountability mostly manual.
Migration runs in parallel during weeks 2–3 of the implementation roadmap. Active patients move first, then historical data. EliteMed picks up billing on day one of go-live; CO-22, CO-50, CO-96, and CO-197 denial patterns get audited in the first 30 days.
Get a free billing audit →Multi-site behavioral health network adding OTP services
Pain: Existing behavioral health EMR doesn’t handle methadone dosing, DEA Form 222, or weekly bundle billing without expensive customization.
The bundle slots in alongside an existing behavioral health platform, owning the OTP layer (clinical + billing + compliance) while the broader network keeps its current EHR for non-OTP services. Reporting rolls up to network leadership through unified RCM dashboards.
Plan a multi-site rollout →Answers OTP buyers actually ask
Direct answers to the questions that come up in every demo. For deeper EMR detail, see the MASE OTP EMR page; for deeper billing detail, see OTP Billing Services.
What is included in the OTP Complete Solution?
How much does the bundle cost?
What is Growth Bridge eligibility?
Can I use just MASE without EliteMed billing?
Can I use EliteMed billing with my current EMR?
How long does implementation take?
Does MASE work with MethaSpense pumps?
How do you handle DEA compliance?
Is this 42 CFR Part 2 compliant?
Do you support take-home dosing?
How is this different from AZZLY Rize?
How is this different from Kipu Health?
Pick the conversation that fits where you are today
Most OTP teams need either a working demo of the connected platform — or a real, free audit of how their billing is leaking revenue right now. We do both.
Book a 15-min OTP demo
See dosing, biometrics, callback automation, take-home workflows, and clinical-to-claim flow in a live walkthrough. Growth Bridge eligibility checked during the call.
Get a free OTP billing audit
Send us your last 90 days. We’ll return a written audit covering denial patterns (CO-22, CO-50, CO-96, CO-197), missing add-on revenue (G2078/G2079), prior-auth gaps, and weekly bundle optimization opportunities. No obligation.